NCT05774938

Brief Summary

The goal of this prospective observational cohort study is to compare health related quality of life in patients with abdominal aortic aneurysms treated by either standard or complex EVAR (endovascular aneurysm repair) devices. The main questions it aims to answer are:

  • Compare differences between the physical scores from the preoperative to the postoperative settings between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR)
  • To compare long-term physical scores postoperatively between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR) at one year.
  • To explore at which time points (if ever) patients treated with standard-EVAR and nonstandard endovascular aortic repair (F-/BEVAR) have restored or normalized physical scores measured by SF-12, measured at 30 days, 6 months, 1 and 3 years. Participants will be asked to fill out forms pre- and postoperatively with regards to health related quality of life. The different groups for comparison will be either standard EVAR for infrarenal aortic aneurysms or complex EVAR (fenestrated or branched) for paravisceral aortic aneurysms (PVAAA).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
44mo left

Started Feb 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Feb 2023Jan 2030

Study Start

First participant enrolled

February 28, 2023

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

April 10, 2025

Status Verified

April 1, 2025

Enrollment Period

3.8 years

First QC Date

March 7, 2023

Last Update Submit

April 8, 2025

Conditions

Keywords

Endovascular aneurysm repairPararenal aortic aneurysmQuality of lifeParavisceral aortic aneurysmFenestrated endovascular aortic repairBranched endovascular aortic repair

Outcome Measures

Primary Outcomes (1)

  • Early physical component score changes after standard or complex EVAR procedure.

    To compare the difference between the physical scores from the preoperative to the postoperative settings between patients treated with standard EVAR vs non-standard endovascular aortic repair (F-/BEVAR) at 30 days.

    2026

Secondary Outcomes (2)

  • Late physical component score changes after standard or complex EVAR procedure.

    2026

  • When does physical component scores return to normal after standard or complex EVAR procedures?

    2028

Study Arms (2)

Standard EVAR

Infrarenal abdominal aortic aneurysms treated with standard EVAR off-the-shelf devices.

Procedure: Standard Endovascular aneurysm repair (sEVAR)

Complex EVAR

Paravisceral aortic aneurysms treated with fenestrated or branched EVAR devices.

Procedure: Complex Endovascular Aneurysm Repair (cEVAR)

Interventions

Standard EVAR treatment with Medtronic Endurant IIs (Medtronic, Inc. - Minneapolis, Minnesota), Gore Excluder AAA (W. L. Gore \& Associates, Inc. - Newark, Delaware), Gore Excluder Conformable AAA (W. L. Gore \& Associates, Inc. - Newark, Delaware), Cook Zenith Flex (Cook Medical, Inc. - Bloomington, Indiana).

Standard EVAR

Complex EVAR treatment with custom made devices (CMD's) from Cook Medical (Cook Medical, Inc. - Bloomington, Indiana) including fenestrated or branched devices or off-the-shelf T-branch device (Cook Medical, Inc. - Bloomington, Indiana).

Complex EVAR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with infrarenal or paravisceral aortic aneurysms planned for treatment with EVAR or F-/BEVAR will be invited to participate in the study at the time of consent of the proposed treatment

You may qualify if:

  • Men and women.
  • Any age (≥18 years)
  • Planned (elective) endovascular treatment by EVAR, FEVAR or BEVAR.
  • Patients previously treated by EVAR which are planned for an adjunct fenestrated cuff will not be included in the basic analysis, but included and analysed separately.

You may not qualify if:

  • Inability to understand and/or respond to the study questionnaires that are in Swedish.
  • Inability to provide an informed consent for participation in the study, orally or in writing (This may be due to linguistic or cognitive limitation).
  • Participation in other ongoing studies concerning quality of life.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 17176, Sweden

RECRUITING

MeSH Terms

Conditions

Aortic AneurysmAortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

AneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Central Study Contacts

Rebecka Hultgren, MD, PhD

CONTACT

Mårten Huss, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct professor

Study Record Dates

First Submitted

March 7, 2023

First Posted

March 20, 2023

Study Start

February 28, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

January 1, 2030

Last Updated

April 10, 2025

Record last verified: 2025-04

Locations